Jump to Main ContentJump to Primary Navigation

Genetic screening may be under UK threat

    A row has erupted over a potential government decision to discontinue screening for life-shortening diseases that have a high degree of frequency in the Ashkenazi Jewish community.

    Representatives of Jewish Genetic Disorders UK, which monitors genetic conditions relevant to people of Jewish ancestry, said they felt “deeply concerned” following a meeting with members of a government advisory body last week, the UK National Screening Committee.

    The meeting involved a discussion of testing for genetic disorders prominent in the Jewish community. The committee was said to be considering available evidence for screening all UK Ashkenazi Jews for Tay Sachs, Canavan disease and Familial Dysautonomia (FD).

    Though the decision will not be disclosed until April 17, JGD policy adviser Sara Conway said they were “deeply concerned that the National Screening Committee may decide to discontinue recommending carrier screening for Tay Sachs disease.

    “This will make it extremely difficult for our at-risk community to access this vital testing,” she added.

    Screening funded by NHS looks likely to fall between different agencies

    Canavan disease is a life-shortening progressive disease of the central nervous system. The carrier frequency in the Ashkenazi Jewish population is approximately 1 in 50.

    Familial dysautonomia, for which there is no cure, is a progressive disorder which affects the autonomic and sensory nervous systems. Approximately one in 30 Ashkenazi Jews carry the recessive FD gene and more than 99 per cent of FD cases occur in Ashkenazi Jews.

    Tay Sachs disease (TSD) is a severe neurological degenerative disease. Affected infants rarely survive past the age of four. The carrier frequency of TSD in Ashkenazi Jews is approximately 1 in 27.

    At the moment, the National Health Service recommends Tay Sach screening for at risk populations. Costs for testing for Tay Sachs vary, but is currently free in London on the NHS, according to Ms Conway.

    “We welcome the NSC’s support for the principle of carrier testing in areas of high Jewish population, but in practice this NHS -funded service looks likely to fall between different agencies,” she said. ”

    “JGD UK will continue working with the Board of Deputies, Jewish Care and other key stakeholders to ensure that this very important issue of testing for Jewish genetic disorders is effectively addressed by NHS commissioning bodies.”

    Jewish Care currently run public screening sessions for Tay Sachs. Guy’s Hospital also operates a walk-in clinic on Monday mornings.

Uk News

Livingstone decision shameful, says Tom Watson

Lee Harpin and Marcus Dysch

Wednesday, April 5, 2017

Livingstone decision shameful, says Tom Watson
Uk News

Anti-Israel conference faces delay

Lee Harpin

Thursday, January 19, 2017

Anti-Israel conference faces delay
Uk News

Commission criticised over inquiry into 'antisemitic' charity

Daniel Sugarman

Monday, December 5, 2016

Commission criticised over inquiry into 'antisemitic' charity
Uk News

Strictly Orthodox Ukip candidate 'should not run for office'

Marcus Dysch

Tuesday, February 28, 2017

Strictly Orthodox Ukip candidate 'should not run for office'
Special Reports

Dublin benefits from overseas aid

Barry Toberman

Sunday, January 8, 2017

Dublin benefits from overseas aid
Uk News

Luciana Berger troll driven by 'fierce antisemitism'

JC Reporter

Monday, December 5, 2016

Luciana Berger troll driven by 'fierce antisemitism'
Uk News

Government drops pledge to aid 3,000 child refugees

Rosa Doherty

Wednesday, February 8, 2017

Government drops pledge to aid 3,000 child refugees
Uk News

Limmud: Food for thought at session on 'ethical eating'

By Simon Rocker

Tuesday, December 27, 2016

Limmud: Food for thought at session on 'ethical eating'
Uk News

Local MP blocks visit from David Irving's 'secret tour'

Rosa Doherty

Friday, December 2, 2016

Local MP blocks visit from David Irving's 'secret tour'